The Dynamic Risk of COVID-19-Related Events in Vaccinated Healthcare Workers (HCWs) from a Tertiary Hospital in Bucharest, Romania: A Study Based on Active Surveillance Data

Author:

Chivu Carmen-Daniela12ORCID,Crăciun Maria-Dorina12ORCID,Pițigoi Daniela13ORCID,Aramă Victoria34,Luminos Monica Luminița35,Jugulete Gheorghiță35ORCID,Constantin Ciprian67ORCID,Apostolescu Cătălin Gabriel34,Streinu Cercel Adrian34

Affiliation:

1. Department of Epidemiology 1, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania

2. Emergency Clinical Hospital for Children “Grigore Alexandrescu”, 011743 Bucharest, Romania

3. National Institute for Infectious Diseases “Prof. Dr. Matei Balș”, 021105 Bucharest, Romania

4. Department of Infectious Diseases 1, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania

5. Department of Infectious Diseases 3, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania

6. Department of Clinical Sciences, Faculty of Medicine, Titu Maiorescu University, 031593 Bucharest, Romania

7. Carol Davila Central Military Emergency University Hospital, 010825 Bucharest, Romania

Abstract

Our study describes the frequency and severity of COVID-19 in HCWs and estimates the dynamic risk of COVID-19-related events. We actively surveyed all HCWs from a tertiary infectious disease hospital from 26 February 2020 to 31 May 2023. Of 1220 HCWs, 62.9% (767) had at least one COVID-19 episode. The under 29 years (p = 0.0001) and 40–49 years (p = 0.01) age groups, nurses (p = 0.0001), and high-risk departments (p = 0.037) were characteristics significantly more frequent in HCWs with COVID-19 history. A higher percentage of boosters (53.2%; p < 0.0001) were registered in the uninfected group. The second episode of COVID-19 was significantly milder than the first. Data regarding clinical outcomes from 31 January 2021 to 31 May 2023 were analyzed in a follow-up study to determine the risk of COVID-19-related events. The Cox regression analysis revealed that HCWs with booster shots had a lower risk of COVID-19 across all events, symptomatic events, and moderate to severe events as adjusted hazard ratio (aHR) were: 0.71 (95%CI: 0.54–0.96), 0.23 (95%CI: 0.12–0.46), and 0.17 (95%CI: 0.07–0.43), respectively. Within the vaccinated subgroup, the HCWs with hybrid immunity and booster had aHR for all followed-up events of 0.42 (95%CI: 0.30–0.58), for symptomatic events of 0.52 (95%CI: 0.36–0.74), and 0.15 (95%CI: 0.03–0.66) for moderate to severe events. The risk of COVID-19 clinical events was lower for HCWs with at least one booster than those completely vaccinated.

Publisher

MDPI AG

Reference36 articles.

1. (2023, December 09). Statement on the Fifteenth Meeting of the IHR (2005) Emergency Committee on the COVID-19 Pandemic. Available online: https://www.who.int/news/item/05-05-2023-statement-on-the-fifteenth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic.

2. (2023, December 09). Interim Recommendations for the Use of mRNA COVID-19 Vaccines. Available online: https://www.who.int/publications-detail-redirect/WHO-2019-nCoV-vaccines-SAGE-recommendation-mRNA-2023.

3. (2023, December 09). Interim Recommendations for the Use of Inactivated COVID-19 Vaccines. Available online: https://www.who.int/publications-detail-redirect/WHO-2019-nCoV-vaccines-SAGE-recommendation-inactivated-2023.1.

4. (2023, December 09). WHO SAGE Roadmap for Prioritizing Uses of COVID-19 Vaccines: An Approach to Optimize the Global Impact of COVID-19 Vaccines, Based on Public Health Goals, Global and National Equity, and Vaccine Access and Coverage Scenarios (Version 21 January 2022)—World|ReliefWeb. Available online: https://reliefweb.int/report/world/who-sage-roadmap-prioritizing-uses-covid-19-vaccines-approach-optimize-global-impact.

5. (2023, December 09). WHO Coronavirus (COVID-19) Dashboard. Available online: https://covid19.who.int.

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3